Renalytix AI Sees Major Stake Shift
Company Announcements

Renalytix AI Sees Major Stake Shift

Renalytix AI (GB:RENX) has released an update.

Renalytix PLC has reported a significant change in ownership, with Harwood Capital LLP and its affiliated entities crossing a notable threshold of voting rights on April 29, 2024. The increase in Harwood Capital’s position to 9.19% represents a shift in stake from the previous 8.69%. The transaction, involving various classes of shares, reflects a strategic investment move in the UK-based Renalytix AI.

For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskRenalytix AI Reduces Debt with New Share Issue
TheFlyRenalytix announces collaboration with Steno Diabetes Center
GlobeNewswireRenalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!